Literature DB >> 26002098

Preliminary study on brominated dioxins/furans and hydroxylated/methoxylated PBDEs in Baltic cod (Gadus morhua) liver. Comparison to the levels of analogue chlorinated co-occurring pollutants.

Marek Roszko1, Krystyna Szymczyk2, Małgorzata Rzepkowska3, Renata Jędrzejczak2.   

Abstract

Low pg levels of PBDD/Fs in 0.8-38.9 pg g(-1) (fat) range (mean 14.2 pg g(-1)) observed in the tested cod liver samples were significantly lower than levels of their chlorinated analogues (25.1-95.9 range, 37.7 mean pg g(-1) fat). Brominated furans dominated the congener profile. Elevated levels of OH-/MeO-BDE were however observed with mean concentrations at 2769±1319 and 5441±2918 pg g(-1) (fat) respectively. The observed congener profiles with the predominance of 6-OH-BDE 47 and the relatively high proportion between the native and hydroxylated compounds indicate on natural origin of those compounds or at least presence of various exposure sources. A large fraction of studied samples did not comply with the currently standing EU regulations concerning PCBs and chlorinated dioxins (11%), especially as regards non-dioxin like PCBs (88%).
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Baltic cod; Brominated dioxins/furans; Hydroxylated; Methoxylated; PBDE; PCB

Mesh:

Substances:

Year:  2015        PMID: 26002098     DOI: 10.1016/j.marpolbul.2015.05.032

Source DB:  PubMed          Journal:  Mar Pollut Bull        ISSN: 0025-326X            Impact factor:   5.553


  2 in total

1.  Uptake and biotransformation of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) in four marine microalgae species.

Authors:  Beverly H K Po; Ka-Lok Ho; Michael H W Lam; John P Giesy; Jill M Y Chiu
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

2.  Endocrine disrupting potency of organic pollutant mixtures isolated from commercial fish oil evaluated in yeast-based bioassays.

Authors:  Marek Łukasz Roszko; Marta Kamińska; Krystyna Szymczyk; Katarzyna Piasecka-Jóźwiak; Beata Chabłowska
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.